Qiaoling Li Selected Research

Infarction (Infarctions)

12/2019

Long non-coding RNA MEG3 knockdown attenuates endoplasmic reticulum stress-mediated apoptosis by targeting p53 following myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiaoling Li Research Topics

Disease

7	Infections 01/2023 - 01/2013
4	Myocardial Infarction 01/2023 - 01/2015
4	Neoplasms (Cancer) 01/2022 - 01/2012
3	Inflammation (Inflammations) 02/2023 - 01/2020
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2016
2	Cognitive Dysfunction 06/2023 - 10/2019
2	Neuroinflammatory Diseases 02/2023 - 01/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2022 - 02/2018
2	Hypoxia (Hypoxemia) 12/2022 - 05/2014
2	Necrosis 01/2022 - 08/2020
2	Hypertension (High Blood Pressure) 07/2021 - 01/2020
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2020 - 01/2019
2	Brain Ischemia (Cerebral Ischemia) 08/2020 - 01/2019
1	Hypertrophic Cicatrix (Hypertrophic Scar) 08/2023
1	Ulcerative Colitis 05/2023
1	Epilepsy (Aura) 02/2023
1	Status Epilepticus (Complex Partial Status Epilepticus) 02/2023
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Death (Near-Death Experience) 01/2023
1	ST Elevation Myocardial Infarction 01/2023
1	Wounds and Injuries (Trauma) 10/2022
1	Left Ventricular Dysfunction 02/2022
1	Burns 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Diabetes Mellitus 12/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020
1	Dyslipidemias (Dyslipidemia) 12/2020
1	Ischemic Stroke 08/2020
1	Hyperplasia 01/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Neointima 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Atherosclerosis 01/2020
1	Hemorrhage 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Infarction (Infarctions) 12/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2019

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2016
3	AminoglycosidesIBA 01/2023 - 01/2021
3	Therapeutic UsesIBA 01/2022 - 09/2019
2	Serum AlbuminIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2016
2	florfenicolIBA 01/2021 - 01/2021
2	Streptozocin (Streptozotocin)FDA Link 12/2020 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 12/2020 - 01/2019
2	HMGB1 Protein (HMG1)IBA 08/2020 - 01/2019
1	Competitive Endogenous RNAIBA 08/2023
1	beta CateninIBA 08/2023
1	Liposomes (Liposome)IBA 05/2023
1	theasinensin AIBA 02/2023
1	Protein Isoforms (Isoforms)IBA 02/2023
1	Complement C3 (C3 Complement)IBA 02/2023
1	Pyruvate KinaseIBA 02/2023
1	Pilocarpine (Ocusert)FDA LinkGeneric 02/2023
1	LactamsIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	SuspensionsIBA 10/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	NucleotidyltransferasesIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	2-hexyl-4-pentynoic acidIBA 01/2022
1	L 30 (L-30)IBA 01/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Kanamycin KinaseIBA 10/2021
1	CoagulaseIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2020
1	punicalaginIBA 12/2020
1	NF-kappa B (NF-kB)IBA 08/2020
1	Complement Factor B (Factor B)IBA 08/2020
1	Toll-Like Receptor 4IBA 08/2020
1	Oxygen (Dioxygen)IBA 08/2020
1	Glucose (Dextrose)FDA LinkGeneric 08/2020
1	ColforsinIBA 01/2020
1	PCSK9 InhibitorsIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	LipidsIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	CholesterolIBA 01/2020
1	Heme (Haem)IBA 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	Gallic AcidIBA 01/2020
1	IronIBA 01/2020
1	Long Noncoding RNAIBA 12/2019
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 10/2019
1	Polycomb Repressive Complex 1IBA 06/2019
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 06/2019
1	Ubiquitin-Conjugating EnzymesIBA 06/2019
1	GlypicansIBA 06/2019

Therapy/Procedure

4	Therapeutics 12/2020 - 09/2006
1	Meditation 06/2023
1	Radiotherapy 12/2022
1	Percutaneous Coronary Intervention 01/2020